Safety in the treatment of infections during pregnancy has not been established. If administration to pregnant patients is considered necessary, its potential benefits should be weighed against the possible hazards to the fetus. There is evidence to suggest that the drug can penetrate the placental barrier and detectable in the milk of nursing mothers. Safety of Sodium Fusidate for the treatment of infections in women who are breast feeding has not been established.